No results, please enter a search term above
Topic |
Priority |
Date of Alert |
|---|---|---|
|
Advisory |
October 7, 2025 |
|
|
Update |
June 10, 2025 |
|
|
Alert |
December 11, 2024 |
|
|
Alert |
September 25, 2024 |
|
|
Alert |
May 13, 2024 |
|
|
Alert |
March 14, 2024 |
|
|
Advisory |
August 18, 2023 |
|
|
Update |
June 26, 2023 |
|
|
Alert |
December 21, 2022 |
|
|
Update |
December 8, 2022 |
These resources, developed by the Division of Substance Use Prevention and Harm Reduction (SUPHR) at the Philadelphia Department of Public Health (PDPH) and Substance Use Response, Guidance, and Education (SURGE) at the Health Federation of Philadelphia, summarize recommendations for best-practices in providing care for individuals with substance use disorder.
Xylazine-associated wounds are a distinct and new presentation of complications associated with substance use. In the absence of evidence-based practices for treating xylazine-associated wounds, clinicians and non-clinicians with experience caring for individuals with xylazine-associated wounds are well positioned to identify best-practices.
This report, developed by the Division of Substance Use Prevention and Harm Reduction (SUPHR) at the Philadelphia Department of Public Health (PDPH) and Substance Use Response, Guidance, and Education (SURGE) at the Health Federation of Philadelphia, summarizes recommendations for best-practices in providing care for individuals with xylazine-associated wounds.
In 2023, 70% of overdose deaths in Philadelphia involved a stimulant. Despite the pervasiveness of stimulant use in the city, healthcare providers are often not equipped to address stimulant use disorder in clinical settings. This toolkit created by SUPHR describes what stimulants are, the health risks associated with stimulant use and current evidence on managing stimulant use disorder.
In response to the changing drug supply, Philadelphia hospitals are developing strategies and adapting protocols to improve withdrawal treatment for people who use drugs. In addition, regulation changes are facilitating hospital methadone initiation. Thus, hospitals and emergency rooms can now do more than ever to provide excellent care to Philadelphians suffering from substance use disorder. This toolkit created by SUPHR contains scalable and effective strategies for managing withdrawal, initiating methadone in the hospital, and ensuring post-discharge continuity of care.